Business Daily from THE HINDU group of publications
Wednesday, Jul 23, 2008
ePaper | Mobile/PDA Version | Audio

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals
Lupin consolidated Q1 net profit up

Mumbai, July 22

Growth across its international markets has helped Lupin double its consolidated net profit for the quarter ended June 30, 2008. The Mumbai-based drug maker posted a net profit of Rs 112 crore for the period under review, as compared to Rs 55 crore in the corresponding period of the previous year. Total income has increased to Rs 882 crore (Rs 591 crore) . Close to 60 per cent of its revenues comes from international markets. The company's standalone net profit of Rs 108 crore for the period under review, was up 38 per cent over Rs 78 crore, clocked in the same period last year. Total income increased to Rs 731 crore (Rs 616 crore). -Our Bureau

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Thermax net up 14 %


Consolidated net of TRF at Rs 8 cr
Lupin consolidated Q1 net profit up
Century Text Q1 net dips 40%, sales up 14%
Siemens profit doubles at Rs 169 cr
Tata Elxsi profit dips 41% on project delays
NIIT Tech Q1 net flat at Rs 35 cr; revenues rise 7%
Four Soft Q1 net rises
Magma Shrachi net rises 58%
Tata Coffee consolidated net up 15% in Q1
Bank of Rajasthan net up at Rs 31 cr
IDBI Bank Q1 net profit marginally up at Rs 160 cr

Smartbuy



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line